These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 6322211)
1. Depressant effects of the interferon inducer polyriboinosinic:polyribocytidylic acid on cytochrome P-450 hemoproteins. Zerkle TB; Wade AE Pharmacology; 1984; 28(1):1-11. PubMed ID: 6322211 [TBL] [Abstract][Full Text] [Related]
2. Suppressive effect of interferon inducer, polyriboinosinic acid-polyribocytidylic acid on induction of uridine diphosphate-glucuronyltransferases and monooxygenases in liver microsomes of rats. Matsunaga T; Nagata K; Hanioka N; Tanaka E; Buppodom P; Oguri K; Yoshimura H J Pharmacobiodyn; 1986 Apr; 9(4):421-7. PubMed ID: 3090228 [TBL] [Abstract][Full Text] [Related]
3. Covalent binding of benzo[a]pyrene to cytochrome P-450 beta NF-B2 and other proteins in reconstituted mixed-function oxidase systems. Schelin C; Wallin H; Halpert J; Jergil B Chem Biol Interact; 1984 May; 49(3):269-81. PubMed ID: 6327095 [TBL] [Abstract][Full Text] [Related]
4. Effect of co-administration of interferon inducer, polyriboinosinic acid-polyribocytidylic acid, with SKF 525-A on hepatic drug metabolizing enzymes of rats. Matsunaga T; Nagata K; Tanaka E; Oguri K; Yoshimura H J Pharmacobiodyn; 1986 Aug; 9(8):638-44. PubMed ID: 3097297 [TBL] [Abstract][Full Text] [Related]
5. Effects of the interferon inducing agents tilorone and polyriboinosinic acid . polyribocytidylic acid (poly IC) on the hepatic monooxygenase systems of the developing neonatal rat. Robbins MS; Mannering GJ Biochem Pharmacol; 1984 Apr; 33(8):1223-7. PubMed ID: 6712732 [TBL] [Abstract][Full Text] [Related]
6. Interaction of the substrate analogue of cytochrome P-450 and mixed function oxidases. Popova VI; Leonova IN; Weiner LM; Salganik RI Biochem Pharmacol; 1982 Jun; 31(11):1993-8. PubMed ID: 6288047 [TBL] [Abstract][Full Text] [Related]
7. Interaction of constitutive and phenobarbital-induced cytochrome P-450 isozymes during the sequential oxidation of benzphetamine. Explanation for the difference in benzphetamine-induced hydrogen peroxide production and 455-nm complex formation in microsomes from untreated and phenobarbital-treated rats. Jeffery EH; Mannering GJ Mol Pharmacol; 1983 May; 23(3):748-57. PubMed ID: 6865917 [TBL] [Abstract][Full Text] [Related]
8. The effects of an interferon inducer, polyriboinosinic polyribocytidylic acid on cytochrome P-450 dependent hepatic progesterone metabolism. Wong JY; Lee EJ; Moochhala SM Life Sci; 1993; 53(25):1893-901. PubMed ID: 8255150 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the microsomal cytochrome P-450 species induced in rat liver by 2-acetylaminofluorene. Aström A; Meijer J; DePierre JW Cancer Res; 1983 Jan; 43(1):342-8. PubMed ID: 6291757 [TBL] [Abstract][Full Text] [Related]
10. Treatment with poly I.C. enhances lipid peroxidation and the activity of xanthine oxidase, and decreases hepatic P-450 content and activities in mice and rats. Koizumi A; Walford RL; Imamura T Biochem Biophys Res Commun; 1986 Jan; 134(2):632-7. PubMed ID: 3753866 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of the synthesis of hepatic cytochrome P-450 by the interferon-inducing agent poly rI.rCi. Singh G; Renton KW Can J Physiol Pharmacol; 1984 Apr; 62(4):379-83. PubMed ID: 6733584 [TBL] [Abstract][Full Text] [Related]
12. Differential effects of proteinase K on the components of the liver microsomal cytochrome P-450 mixed function oxidase system. Shen TL; Zhuang ZP; McCauley R; Putt D; Hollenberg PF Drug Metab Dispos; 1991; 19(6):1016-21. PubMed ID: 1687005 [TBL] [Abstract][Full Text] [Related]
13. Suppression of hepatic drug metabolism by the interferon inducer, polyriboinosinic acid:polyribocitidylic acid. Sakai H; Okamoto T; Kikkawa Y J Pharmacol Exp Ther; 1992 Oct; 263(1):381-6. PubMed ID: 1403800 [TBL] [Abstract][Full Text] [Related]
14. Cytochrome P-450 induction by clofibrate. Purification and properties of a hepatic cytochrome P-450 relatively specific for the 12- and 11-hydroxylation of dodecanoic acid (lauric acid). Gibson GG; Orton TC; Tamburini PP Biochem J; 1982 Apr; 203(1):161-8. PubMed ID: 7103935 [TBL] [Abstract][Full Text] [Related]
15. Role of colonic cytochrome P-450 in large bowel carcinogenesis. Strobel HW; Fang WF; Oshinsky RJ Cancer; 1980 Mar; 45(5 Suppl):1060-5. PubMed ID: 6766798 [TBL] [Abstract][Full Text] [Related]
16. Alterations of microsomal monooxygenase system and carcinogen metabolism by streptozotocin-induced diabetes in rats. Peng R; Tennant P; Lorr NA; Yang CS Carcinogenesis; 1983; 4(6):703-8. PubMed ID: 6305526 [TBL] [Abstract][Full Text] [Related]
18. Effect of hyperthyroidism on the in vitro metabolism and covalent binding of 1,1-dichloroethylene in rat liver microsomes. Gunasena GH; Kanz MF J Toxicol Environ Health; 1997 Oct; 52(2):169-88. PubMed ID: 9310148 [TBL] [Abstract][Full Text] [Related]
19. Immunochemical study on the contributions of two molecular species of microsomal cytochrome P-450 to the metabolism of benzo(a)pyrene by rat liver microsomes. Hara E; Kawajiri K; Tagashira Y Cancer Res; 1983 Aug; 43(8):3604-8. PubMed ID: 6305488 [TBL] [Abstract][Full Text] [Related]
20. Purification and characterization of a cytochrome P-450 isozyme catalyzing bunitrolol 4-hydroxylation in liver microsomes of male rats. Suzuki T; Narimatsu S; Fujita S; Masubuchi Y; Umeda S; Imaoka S; Funae Y Drug Metab Dispos; 1992; 20(3):367-73. PubMed ID: 1355709 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]